The White House is hosting a global Covid response summit this week — but the U.S. isn't currently prepared to bring significant new money to fight the virus worldwide, according to two people familiar with the preparations.
The pandemic has generated gigabytes of data that make clear which U.S. groups have been hit the hardest. More than 700,000 people 65 and older died. Men died at higher rates than women.
An additional booster dose of COVID vaccine helped substantially reduce the rate of infection in nursing home residents during the Omicron wave compared with a primary series alone, researchers found.
While the U.S. waits on funding and for the U.S. Food and Drug Administration (FDA) to decide on which virus strain to attack through boosters, Moderna and other vaccine companies are anticipating waning immunity to become a concern.
"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told Yahoo Finance. "As you see more and more infectious variants ... We are not done with this virus mutating," he said.
The biggest risk in the fall, if boosting is delayed, is the potential for hospitals to fill up with those that are the most vulnerable all over again, Bancel said.
The increased circulation from the intersection of waning immunity and a more transmissible variant, as is being observed with more Omicron subvariants in the U.S. and abroad, is the real risk, he said.
"We have a risk in the fall — if we don't have the booster campaign early enough —that we might not be in a great spot in the fall," Bancel said.
WASHINGTON (AP) — For the first time, the U.S. came close to providing health care for all during the coronavirus pandemic — but for just one condition, COVID-19.
Recent Comments